MERCATALI, LAURA
MERCATALI, LAURA
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models
2023 Guerrieri A.N.; Bellotti C.; Penzo M.; Columbaro M.; Pannella M.; De Vita A.; Gambarotti M.; Mercatali L.; Laranga R.; Dozza B.; Vanni S.; Corsini S.; Frisoni T.; Miserocchi G.; Ibrahim T.; Lucarelli E.
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
2023 Miserocchi G.; Bocchini M.; Cortesi M.; Arienti C.; De Vita A.; Liverani C.; Mercatali L.; Bravaccini S.; Ulivi P.; Zanoni M.
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
2023 Liverani, Chiara; Spadazzi, Chiara; Ibrahim, Toni; Pieri, Federica; Foca, Flavia; Calabrese, Chiara; De Vita, Alessandro; Miserocchi, Giacomo; Cocchi, Claudia; Vanni, Silvia; Ercolani, Giorgio; Cavaliere, Davide; Ranallo, Nicoletta; Chiadini, Elisa; Prisinzano, Giovanna; Severi, Stefano; Sansovini, Maddalena; Martinelli, Giovanni; Bongiovanni, Alberto; Mercatali, Laura
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
2023 Fausti, Valentina; De Vita, Alessandro; Vanni, Silvia; Ghini, Virginia; Gurrieri, Lorena; Riva, Nada; Casadei, Roberto; Maraldi, Marco; Ercolani, Giorgio; Cavaliere, Davide; Pacilio, Carlo Alberto; Pieri, Federica; Foca, Flavia; Bongiovanni, Alberto; Ranallo, Nicoletta; Calpona, Sebastiano; Frassineti, Giovanni Luca; Ibrahim, Toni; Mercatali, Laura
A Modular Composite Device of Poly(Ethylene Oxide)/Poly(Butylene Terephthalate) (PEOT/PBT) Nanofibers and Gelatin as a Dual Drug Delivery System for Local Therapy of Soft Tissue Tumors
2022 Liguori, Anna; De Vita, Alessandro; Rossi, Giulia; Dolci, Luisa Stella; Panzavolta, Silvia; Gualandi, Chiara; Mercatali, Laura; Ibrahim, Toni; Focarete, Maria Letizia
New Ground-Breaking Strategies in Bone Regeneration—In Memory of Nerio Ceroni
2022 De Vita A.; Donati D.M.; Mercatali L.; Ibrahim T.
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis
2021 Di Pompo G.; Errani C.; Gillies R.; Mercatali L.; Ibrahim T.; Tamanti J.; Baldini N.; Avnet S.
Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic Surgeons
2020 Guerrieri A.N.; Montesi M.; Sprio S.; Laranga R.; Mercatali L.; Tampieri A.; Donati D.M.; Lucarelli E.
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells
2020 Napolitano R.; de Matteis S.; Carloni S.; Bruno S.; Abbati G.; Capelli L.; Ghetti M.; Bochicchio M.T.; Liverani C.; Mercatali L.; Calistri D.; Cuneo A.; Menon K.; Musuraca G.; Martinelli G.; Simonetti G.
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
2017 Fici P.; Gallerani G.; Morel A.-P.; Mercatali L.; Ibrahim T.; Scarpi E.; Amadori D.; Puisieux A.; Rigaud M.; Fabbri F.
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact
2013 Ibrahim T.; Farolfi A.; Scarpi E.; Mercatali L.; Medri L.; Ricci M.; Nanni O.; Serra L.; Amadori D.
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact
2013 Ibrahim T.; Farolfi A.; Mercatali L.; Ricci M.; Amadori D.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models | Guerrieri A.N.; Bellotti C.; Penzo M.; Columbaro M.; Pannella M.; De Vita A.; Gambarotti M.; Merc...atali L.; Laranga R.; Dozza B.; Vanni S.; Corsini S.; Frisoni T.; Miserocchi G.; Ibrahim T.; Lucarelli E. | 2023-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Paper Rizzoli 2023.pdf |
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension | Miserocchi G.; Bocchini M.; Cortesi M.; Arienti C.; De Vita A.; Liverani C.; Mercatali L.; Bravac...cini S.; Ulivi P.; Zanoni M. | 2023-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-14-1171141.pdf |
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors | Liverani, Chiara; Spadazzi, Chiara; Ibrahim, Toni; Pieri, Federica; Foca, Flavia; Calabrese, Chia...ra; De Vita, Alessandro; Miserocchi, Giacomo; Cocchi, Claudia; Vanni, Silvia; Ercolani, Giorgio; Cavaliere, Davide; Ranallo, Nicoletta; Chiadini, Elisa; Prisinzano, Giovanna; Severi, Stefano; Sansovini, Maddalena; Martinelli, Giovanni; Bongiovanni, Alberto; Mercatali, Laura | 2023-01-01 | FRONTIERS IN ENDOCRINOLOGY | - | 1.01 Articolo in rivista | 2023-Liverani (front Oncol)-HRAS overexspression in pancreatic neuroendocrine tumor.pdf; DataSheet_1.pdf |
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin | Fausti, Valentina; De Vita, Alessandro; Vanni, Silvia; Ghini, Virginia; Gurrieri, Lorena; Riva, N...ada; Casadei, Roberto; Maraldi, Marco; Ercolani, Giorgio; Cavaliere, Davide; Pacilio, Carlo Alberto; Pieri, Federica; Foca, Flavia; Bongiovanni, Alberto; Ranallo, Nicoletta; Calpona, Sebastiano; Frassineti, Giovanni Luca; Ibrahim, Toni; Mercatali, Laura | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | 2023-Fausti (Cancers)- Systemic inflammation and soft tissue sarcoma.pdf |
A Modular Composite Device of Poly(Ethylene Oxide)/Poly(Butylene Terephthalate) (PEOT/PBT) Nanofibers and Gelatin as a Dual Drug Delivery System for Local Therapy of Soft Tissue Tumors | Liguori, Anna; De Vita, Alessandro; Rossi, Giulia; Dolci, Luisa Stella; Panzavolta, Silvia; Guala...ndi, Chiara; Mercatali, Laura; Ibrahim, Toni; Focarete, Maria Letizia | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | 2022 Int J Mol Sci vol23 ID3239.pdf; supplementary_materials.pdf |
New Ground-Breaking Strategies in Bone Regeneration—In Memory of Nerio Ceroni | De Vita A.; Donati D.M.; Mercatali L.; Ibrahim T. | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-00855.pdf |
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis | Di Pompo G.; Errani C.; Gillies R.; Mercatali L.; Ibrahim T.; Tamanti J.; Baldini N.; Avnet S. | 2021-01-01 | FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | - | 1.01 Articolo in rivista | fcell-09-678532.pdf |
Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic Surgeons | Guerrieri A.N.; Montesi M.; Sprio S.; Laranga R.; Mercatali L.; Tampieri A.; Donati D.M.; Lucarel...li E. | 2020-01-01 | FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY | - | 1.01 Articolo in rivista | fbioe-08-589964.pdf |
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells | Napolitano R.; de Matteis S.; Carloni S.; Bruno S.; Abbati G.; Capelli L.; Ghetti M.; Bochicchio ...M.T.; Liverani C.; Mercatali L.; Calistri D.; Cuneo A.; Menon K.; Musuraca G.; Martinelli G.; Simonetti G. | 2020-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | or-44-04-1561.pdf; Supplementary_Data.pdf |
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer | Fici P.; Gallerani G.; Morel A.-P.; Mercatali L.; Ibrahim T.; Scarpi E.; Amadori D.; Puisieux A.;... Rigaud M.; Fabbri F. | 2017-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact | Ibrahim T.; Farolfi A.; Scarpi E.; Mercatali L.; Medri L.; Ricci M.; Nanni O.; Serra L.; Amadori D. | 2013-01-01 | ONCOLOGY | - | 1.01 Articolo in rivista | - |
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact | Ibrahim T.; Farolfi A.; Mercatali L.; Ricci M.; Amadori D. | 2013-01-01 | TUMORI | - | 1.03 Recensione in rivista | - |